An interventional study of Experimental intervention and Active intervention in Parkinson Disease and Freezing of Gait Symptoms in Parkinson Disease, sponsored by Oregon Health and Science University. Recruiting at 3 sites in 2 countries. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-07-28.
Sponsored by Oregon Health and Science University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 36 studies in Parkinson Disease by Oregon Health and Science University — 4 open to participants now, 4 under way, none of them phase 3. Parkinson Disease · Oregon Health and Science University.
Among the 36 studies in Parkinson Disease by Oregon Health and Science University, this one is the 7th largest by planned enrollment of the 28 interventional ones that give a count, is one of 2 that started in 2025, is one of 17 with no phase, and was the 36th registered.
4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.
Browse Parkinson Disease studies →4 of the 36 studies in Parkinson Disease by Oregon Health and Science University are open now, in 2 countries. Recruiting first, the newest first:
Oregon Health and Science University · Sites in United States
Ages 45–85
Oregon Health and Science University · Sites in United States
Ages 40–90
Oregon Health and Science University · Sites in United States
Ages 55–85
By country, each count listing its studies:
Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.
This study: 50 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
36 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is above the median of 40 across 3,360 interventional studies indexed under Parkinson Disease.
Median enrollment 22 across the 28 interventional studies, 17 across the 8 observational. Of the 26 that completed or were terminated, 10 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
Oregon Health and Science University is the lead sponsor of 697 studies on the registry; 129 are open to participants now.
Of its 53 completed or terminated interventional studies of FDA-regulated products, 39 (74%) have results posted.
3 of the studies in Parkinson Disease by Oregon Health and Science University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06815302Oregon Health and Science UniversityTURN-IT FOG: Improving Turning and Freezing of Gait in People With PD | 2026-12-31 |
| NCT05680597Oregon Health and Science UniversityBalance Tele-Rehab in Parkinson's Disease | 2027-06 |
| NCT05818189Oregon Health and Science UniversityCortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing | 2027-10-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 36 studies in Parkinson Disease by Oregon Health and Science University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goals of this clinical trial are to 1) learn how two different rehabilitation interventions for PD can reduce Freezing of Gait (FOG) in people with Parkinson's disease, as assessed by patients, clinicians, and wearable sensors, and 2) to explore whether two different rehabilitation intervention can reduce FOG and improve daily life mobility in people with FOG sufficiently to justify a clinical trial.
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Six weeks of exercise intervention to improve gait disturbances. Specific participant procedures in experimental and active control interventions are simplified to preserve study blinding.
Behavioral: Experimental intervention
Six weeks of exercise intervention to improve gait disturbances. Specific participant procedures in experimental and active control interventions are simplified to preserve study blinding.
Behavioral: Active intervention
Specific participant procedures in experimental and active control interventions are simplified to preserve study blinding.
Specific participant procedures in experimental and active control interventions are simplified to preserve study blinding.
Patient- Perceived Freezing of Gait Severity
Change in freezing of gait severity with the intervention (scored in likert scale by the patient; 3 = Much improved, 2 = Somewhat improved, 1 = Minimally improved, 0 = No change, -1 = Minimally worse, -2 = Somewhat worse, -3 = Much worse)
Time frame: From enrollment/randomization through intervention; 8 weeks
Clinician- Perceived Freezing of Gait Severity
Change in freezing of gait severity with the intervention (scored in likert scale by the clinician; 3 = Much improved, 2 = Somewhat improved, 1 = Minimally improved, 0 = No change, -1 = Minimally worse, -2 = Somewhat worse, -3 = Much worse
Time frame: From enrollment/randomization through intervention; 8 weeks
Sensors-based Freezing of gait severity
Freezing of Gait Index calculated during a 360 degrees turning in place from wearable sensors; continuous scale, with a higher positive score meaning a greater level of freezing of gait.
Time frame: From enrollment/randomization through intervention; 8 weeks
Time Spent in FOG during daily life
% time spent FOG compared to walking during daily life calculated from wearable sensors
Time frame: From enrollment/randomization through intervention; 8 weeks
Plan to share: Yes — De-identified data related to study outcomes measures will be publicly shared
Time frame: Data would be available 6 months after publication.
Access criteria: Data will be deposited on Zenodo https://zenodo.org/records/12548174
Data sharing details ↗ · zenodo.org
No publications or documents are linked to this record.
Started Jun 2025 (actual). Primary completion is estimated for Dec 2026, 18 months after the start.
Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 18 months is below that.
Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oregon Health and Science University →